Hepatitis A virus (HAV) and hepatitis C virus (HCV) coinfection in patients usually leads to HCV suppression or clearance. Whether this suppression/clearance is caused by direct virus-virus interaction or indirect interactions is still unknown. Here, we present a robust and visualizable HAV/HCV coinfection model for investigating their interactions in vitro. We find that HAV superinfects HCV-persistently-infected Huh-7.5.1 cells without obvious virus-virus exclusion and vice versa, while there is a mild reciprocal viral interference in coinfection. Through single-cell scale confocal microscopy analysis and treating co-infected cells with rNTPs or antivirals e.g. Sofosbuvir, Simeprevir, and Ledipasvir, we find that HAV and HCV exploit cellular machinery in a compatible manner, but with reciprocal competition for rNTPs in their RNA synthesis. In conclusion, our findings reveal the absence of direct HAV-HCV interaction but the presence of indirect interaction, which may be due to limited competition in viral RNA synthesis. Therefore, we propose that suppression/clearance of HCV in HAV/HCV coinfected patients is probably due to indirect interactions e.g. viral competition or immunological interactions.
Introduction
Hepatitis A virus (HAV) and hepatitis C virus (HCV) are both hepatotropic viruses, with HAV usually causing acute infection and HCV often resulting in chronic infection [1] . HAV is a foodborne virus, which is epidemic in hygiene-poor regions and often causes a sporadic outbreak in developed countries [2] . Acute HAV infection often induces nausea, vomiting, diarrhea, jaundice or even liver failure [2] . Although HAV vaccine was accessible two decades ago [3] , potent antivirals against HAV is still in demand [4] . In contrast, HCV is a blood-borne virus, chronically infecting approximately 80 million people worldwide and often leading to liver cirrhosis and even hepatocellular carcinoma [5] . Although efficient direct-acting antivirals (DAAs) against HCV dramatically improved the therapy of chronic hepatitis C, the HCV vaccine has not yet been available [5] .
HAV and HCV are both single-stranded positive-sense RNA viruses, belonging to the Picornaviridea and Flaviviridae respectively [6] . They exhibit many similar biological features. For example, (1) their robust replication in vitro are induced by the cell-culture adapted mutations under experimental selection [7, 8] ; (2) They have a comparable genome structure, which encodes a single polyprotein that is processed by their viral or cellular proteases into separate viral proteins [9, 10] ; (3) Their infections in cells alter the morphology of endoplasmic reticulum (ER). e.g. Tubular-vesicular network by HAV [11] versus membraneous web by HCV [12]; (4) They evade the innate immunity via the same strategy: cleaving IPS-1 to inactivate RIG-I antiviral pathway [13, 14] .
On the other hand, differences between HAV and HCV are obvious. For example, (1) HCV has its own viral membrane proteins E1 and E2 [9] , while HAV is naked or quasi-enveloped through hijacking cellular membranes [15, 16] ; (2) It is well-known that HCV utilizes many cellular receptors for its entry [9] , whereas HAV entry step is still enigmatic as the only known receptor-TIM1 seems not essential for HAV infection [17] .
HAV infection sometimes leads to severe or even fulminant hepatitis in the patient with chronic hepatitis C [18] , which is disputable in different retrospective studies [19] . In contrast, it is a common phenomenon that HAV infection leads to HCV suppression or clearance in HAV/HCV coinfected patients [20, 21] . Indirect interaction mediated by immune response might be one 4 of 22 reason for HCV suppression/clearance. e.g. Cacopardo et al. demonstrated that HAV superinfection-induced IFN-γ production was associated with HCV clearance [22] . Nevertheless, whether the direct virus-virus interaction or some other indirect interactions could contribute to HCV suppression/clearance is still unknown.
In this study, we established a robust and visualizable HAV/HCV coinfection model in Huh-7.5.1 cell to investigate HAV-HCV interactions. Our coinfection model is suitable for studying virus-virus interactions without considering immunological interaction, as Huh-7.5.1 cell is immunocompromised in response to virus infection [23, 24] . Our data revealed the absence of direct HAV-HCV interaction but the presence of reciprocal competition in viral RNA synthesis.
Results

The absence of HAV-HCV exclusion in HAV superinfection revealed by a dual fluorescence reporter system
For visualizing real-time HAV/HCV coinfection with convenience, we combined two real-time detecting systems of HAV and HCV infection in Huh-7.5.1 [25, 26] . In brief, for HAV detection, C508 at IPS-1 was mutated to R508R for excluding the HCV NS3/3A cleavage and GFP (green fluorescent protein) was used ( Fig 1A) ; For HCV detection, RFP (red fluorescent protein ) was used ( Fig 1A) . Because HAV 3ABC and HCV NS3/4A cleave IPS-1 at Q427 and C508 ( Fig 1A) , relocalization of GFP or RFP from cytosol to nucleus could report HAV or HCV infection in the same cell without disturbance (Fig1A, S1 FigC). We designated this dual fluorescence reporter system as Huh-7.5.1-GA/RC, which supported robust infection of both HAV and HCV (S1 Fig A-B) .
HAV superinfection in the patient with chronic hepatitis C is a common phenomenon, we first investigated the HAV superinfection in HCV persistently infected Huh-7.5.1-GA/RC cells ( Fig 1B) .
To note, we applied a high MOI of HAV and HCV infection for ensuring that 90% cells were HAV/HCV co-infected. Seven days post HCV infection, HCV succeeded to infect almost 90% cells ( Fig 1C) and HCV infection did not disturb TIM-1 expression (S1 Fig D) , after which we initiated HAV superinfection. We observed that at least 90% cells were HAV/HCV coinfected from the time of 48 hours post HAV infection to the end of our experiment ( Fig 1D) . These data demonstrated that HAV superinfection did not induce obvious exclusion of HCV replication in the immunocompromised model and there was no obvious superinfection exclusion.
Reciprocal viral interference between HAV and HCV in HAV superinfection
In order to confirm the above finding revealed by the reporter system, we conducted a comprehensive analysis of HAV superinfection via RT-qPCR, western blot, and infectivity titration.
HAV cytopathogenic and non-cytopathogenic strain HM175/18f and HM175/p16 were used, with the former replicating more robustly than the latter (Fig 1A-C ). Compared to their mono-infection, viral proteins expression of HAV and HCV reduced slightly in superinfected cells (Fig 2A, Fig 2D) .
Consistent with this, by RT-qPCR, we observed a mild decrease (5-fold ~ 10-fold reduction) of both HAV and HCV intracellular RNA copies in HAV superinfection ( Fig 2B, Fig 2E) . In addition, we found that extracellular HAV infectivity and VP2 decreased approximately 10-fold in HAV superinfection compared to its mono-infection, whereas extracellular HCV infectivity and core were not disturbed ( Fig 2C, Fig 2F, S2 Fig A-B) .
It is well-known that HAV/HCV infection could lead to cell apoptosis in vitro, which was confirmed by Annexin-V / PI staining in our study (S3 Fig B) . In addition, we found that the percentage of HAV-induced cell loss and apoptosis was less in HAV superinfection than in HAV mono-infection (S3 Fig A-B) , which suggested that the attenuation of HAV replication by HCV may lessen the cell death. We next determined whether the attenuation of HCV replication result from HAV-induced cell death. However, low MOI HM175/18f superinfection and long-term HM175/p16 superinfection still induced a reciprocal interference of their RNA synthesis (S4 Fig A-D) . These data suggested that the attenuation of HAV/HCV replication in their coinfection should not result from cell death.
Direct virus-virus interaction usually exhibits dramatic inhibition of another virus during
coinfection. e.g. over-expression of Borna disease virus (BDV) nucleocapsid components prevented a subsequent infection of a different BDV strain [27] . In this HAV/HCV coinfection model, HAV and HCV replications in Huh-7.5.1 cell were robust, which would provide enough amount of viral proteins for direct interactions. Besides, over-expression of HCV viral structural protein E1, E2, and core in Huh-7.5.1 cells did not affect HAV infection (S5 Fig A-C ). However, we just observed a limited reciprocal viral interference between HAV and HCV (Fig 2) , which suggested that direct interactions between HAV and HCV were absent in HAV/HCV coinfection.
Neighbored HAV/HCV replication complexes and competition in their RNA synthesis
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Next, we dedicated to investigating the mechanism of their reciprocal limited viral interference by confocal microscopy. The localization of their replication complexes (RCs) was observed by labeling their negative-sense RNA by FISH (fluorescent in-situ hybridization). In HAV/HCV coinfected single-cell, their RCs did not co-localize in the cytosol ( Fig 3A) as the Pearson's correlation coefficient of HAV/HCV negative RNA is close to 0 ( Fig 3C) . Moreover, by 3D image reconstruction, we found that their RCs were neighbored to each other ( Fig 3B) . Besides, we simulated viral RCs via RNA spots detected by FISH, which were represented as balls ( Fig 3D) . To note, balls were rendered by the same rule that minimum radius of one ball was determined automatically by iMaris in order to cover one separate RNA spot signal. We found that co-infected cell and mono-infected cell owned equivalent numbers of HAV/HCV RNA spots ( Fig 3E) , whereas the signal intensity of RNA spots slightly reduced in the coinfected cell ( Fig 3F) . Furthermore, strand-specific RT-qPCR confirmed both decrease of their negative-and positive-sense RNAs in HAV/HCV coinfection (S6 Fig) . These data suggested that HAV/HCV coinfection did not alter space occupation of individual viral RCs, but may lead to attenuation of their RNA synthesis.
rNTPs treatment to HAV/HCV coinfection alleviated viral competition in viral RNA synthesis
Both HAV and HCV synthesize their RNA template using rNTPs via their viral RNA-dependent RNA polymerases (Rdrp). Considering the above imaging data, we hypothesized that rNTPs competition in RNA synthesis may result in the reciprocal limited viral interference in HAV/HCV coinfection. Then, we inoculated cells with rNTP four hours post HAV superinfection to see whether extra-added rNTP could rescue the attenuation of their replication in HAV/HCV coinfection. As expected, rNTP increased both HAV and HCV replication significantly in coinfection ( Fig 4A, Fig 4B) . In addition, rNTP increased HAV replication in HAV mono-infection, while it has no effect on HCV replication in HCV persistent infection ( Fig 4A, Fig 4B) . Previously, we found that Sofosbuvir-an analog of rNTPs, inhibited HAV replication with IC50 of 6.8μM, while it inhibited HCV replication more efficiently with IC50 of 0.05μM [26] . Here, in HAV/HCV coinfection, antiviral activity of sofosbuvir against HAV and HCV became worse, compared to that in their monoinfections ( Fig 4C, Fig 4D) . Especially when the Sofosbuvir concentration was at 2000nM, inhibitory effect on HAV was disappeared, though at the same concentration in HAV monoinfection Sofosbuvir inhibited approximately 50% HAV replication ( Fig 4C) . The antiviral activity of 7 of 22 Sofosbuvir against RNA virus is to inhibit viral Rdrps via binding to it, which suggested that HAV and HCV Rdrps even compete for Sofosbuvir. From this result, we demonstrated that rNTPs should be a crucial factor in HAV/HCV coinfection, for which HAV and HCV Rdrps strive against each other for their RNA synthesis.
HCV DAAs treatment to HAV/HCV coinfection lessened the attenuation of HAV replication
On the other hand, Simeprevir and Ledipasvir, which specifically inhibited HCV replication, increased HAV replication in HAV/HCV coinfection ( Fig 4E, Fig 4F) . Finally, we found that IFN-α inhibited both viruses replication ( Fig 4E, Fig 4F) . These results indicated that the attenuation of HAV replication is due to the competition from HCV replication.
HAV/HCV assembly and releasing were not overlapped
By immunofluorescence analysis (IF) of their structural protein, we found that HCV core and HAV VP3 were neighbored but did not show any significant overlapping (the median of their Pearson's correlation coefficient is 0.144) ( Fig 5A, Fig 5C) . In addition, we found the colocalization of HCV core and lipid droplets (LDs), which is consistent with that HCV assembly depends on the lipid pathway [28]. However, there was no colocalization between HAV VP3 and LDs ( Fig 5B, Fig 5C) .
Considering eHAV (enveloped HAV) was shown to acquire the exosome-associated membrane [15, 16] and HCV are reported to be tightly associated with exosome pathway [29], we asked whether HAV could hijack HCV membrane or not ( Fig 5D) . Then, we did a pull-down analysis of HCV virion by immunoprecipitating E2 in cell culture, to check if HAV can be co-precipitated or not.
Approximately 50% HCV infectivity or genomic RNA was pull downed in the eluate from both HAV superinfection and HCV persistent infection. However, we can not observe detectable HAV infectivity or its genomic RNA co-precipitated from HCV virions ( Fig 5E, Fig 5F) . These results indicated that the HAV/HCV assembly and release should not be overlapped.
Reciprocal viral interference between HAV and HCV in HCV superinfection
As limited competition was revealed in the HAV superinfection model without direct viral interaction, we hypothesized that HAV and HCV should co-exist with limited interference whatever the order of superinfection. So we conducted HCV superinfection in HAV infected cells and ensured 90% cells were coinfected (data not shown). As expected, their RNA synthesis, protein expression, and virus production showed reciprocal limited interference ( Fig 6) .
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Discussion
In this study, we established a visualizable in-vitro HAV/HCV co-infection model and made a comprehensive analysis of HAV-HCV interaction in Huh-7.5.1 cell. We monitored the real-time process of HAV/HCV coinfection (including HAV and HCV superinfection) and found that there was no obvious virus-virus exclusion when more than 90% cells were HAV/HCV coinfected. However, a reciprocal limited viral interference was observed, which was consistent with a previous study that HAV and HCV replicases have limited competition in a sub-genomic replicon system [30] . In addition, we identified the mechanism of limited interference.
Virus-virus interactions are common phenomena in natural hosts and can be categorized into three aspects: (1) direct interactions of viral genes or gene product, (2) indirect interactions that result from alterations in the host environment, and (3) immunological effect [31] . First, we exclude the possibility of direct HAV-HCV interactions resulting in limited viral interference. Second, we found that viral competition of rNTP in their RNA synthesis resulted in the reciprocal interference in HAV/HCV coinfection. It is possible that the attenuation of RNA synthesis would affect the downstream of the viral life cycle such as translation and assembly. However, we can not exclude that the limited viral competition occurred throughout their virus life cycles in coinfection. For example, 1) mild reciprocal interference of HAV and HCV viral protein expression indicated that their RNA template might compete to recruit ribosomes for translation; 2) interference on HAV extracellular infectivity might be due to the competition of some host factors such as Rab27a [32], because HCV and HAV releasing are tightly related to the exosome pathways [16, 29, 33 ]. In our model, HAV replication capacity and secretion efficiency was higher than that of HCV, which suggested that HAV need more resource than HCV. However, HAV and HCV can not directly disturb each other i.e. HAV suffers more pressure from the competition than HCV. This may explain why the attenuation of HAV life cycle (especially HM175/18f) was more obvious in coinfection.
Resource competition in virus coinfection has been predicted in several mathematical modelings. In patients, HAV/HCV coinfection would lead to HCV suppression/clearance. In this in-vitro coinfection model, we did not detect any dramatic inhibition of HCV or direct HAV-HCV interactions, which indicated the absence of direct virus interaction in HAV/HCV coinfected patients. Both HAV and HCV are cell-culture adapted strains, which replicate robustly in Huh-7.5.1 cells. In vivo, the replication capacity of wild-type strains in infected patients should be an important factor that determines the occurrence of competition between HAV and HCV in-vivo. For example, HM175/p16 induces weaker viral interference than HM175/18f in HAV/HCV coinfection (with the former replicating less robustly than the latter). In addition, the competition also depends on the proportion of HAV-HCV coinfected hepatocytes in the patient's liver, which is lack in clinical data.
In coinfected patients, an indirect interaction mediated by immunological interaction may be another reason. Cacopardo 
Materials and methods
Plasmids and antibodies
Plasmids pFK-JC1E2 flag have been previously described [37] . Plasmids pGEM3-HM175/18f was a kind gift from Stanley M. Lemon [15] . Plasmids pWPI-blr-GFP-NLS-IPS1, pWPI-puro-RFP-NLS-IPS1 for the fluorescent reporter system were constructed as described previously [26] . Briefly, fragments of GFP-NLS, RFP-NLS, NLS-IPS1(420/540), NLS-IPS1(462/540) were amplified by 10 of 22 PCR. Then GFP-NLS-IPS1(420/540), RFP-NLS-IPS1(462/540) were amplified by overlapping PCR, and inserted into lentiviral plasmid pWPI. Primers are listed in S1 table. Mouse anti-NS5A, rabbit anti-NS5A, rabbit anti-core have been described previously [38] . Rabbit anti-3C, rabbit anti-VP2 were made in home. Other antibodies were purchased as follows: Mouse anti-VP3 (Lifespan), goat anti-actin (Santa-cruz), goat anti-rabbit-HRP (ZSGB-Bio), goat anti-mouse-HRP (ZSGB-Bio), goat anti-mouse/rabbit labeling with Alexa-fluor-488/555® (lifetechnologies). Sofosbuvir, Simeprevir, and Ledipasvir were purchased from MedChem Express. IFN-α was a gift from X.Liu. rNTPs were purchased from Promega.
Cells and viruses
HEK293T, Huh-7.5.1, and its derivative Huh-7.5.1-GA/RC were cultured in DMEM medium supplemented with 2mM L-glutamine, nonessential amino acids, 100U penicillin per ml, 100μg streptomycin per ml and 10% FBS (complete DMEM). Production of JC1E2 flag and HM175/18f have been described previously [15, 38] . Virus stock was stored at -80 after filtration with 0.45μm filters (Millipore). HM175/p16 virus was a kind gift from Stanley Lemon and Zongdi Feng. Infectivity of HAV and HCV were titrated by TCID50 as previously described [38] . Briefly, Huh-7.5.1 cells were seeded in 96-well plate, and one day later, the virus was added to the plate in serial dilution. 3 day later, cells were fixed using cold ethanol and hybridized with mouse anti-NS5A for HCV, while titration of HAV was determined by the HAV fluorescence reporter system-Huh-7.5.1-GA as described previously [26] . For generation of Huh-7.5.1-GA/RC reporter cells, lentiviruses carrying GFP-NLS-IPS1(420/540) and RFP-NLS-IPS1(462/540) were prepared as previously described [38] . Then Huh-7.5.1 was co-transfected by the lentiviruses and screened under blasticidin (4μg/ml) and puromycin (1μg/ml) to generate Huh-7.5.1-GA/RC cell line.
Western blot analysis
Western blot was applied as previously described [38] . Briefly, Samples were collected in Laemmli buffer and separated by SDS polyacrylamide gel electrophoresis. Proteins were transferred onto PVDF membrane, which was blocked using 5% dried milk and incubated with indicated primary antibody and secondary antibody. Bands were visualized by ECL reagent (Bio-Rad) under Tanon 4200. Software Fiji was applied to estimate the band intensity.
RT-qPCR assay for quantification of viral RNA
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Cells were washed with 1×PBS once and the supernatant was filtered by 0.45μm filters prior to adding the TRNzol Universal Reagent (Tiangen). Total cellular RNA was extracted according to the manufacturer's protocol (Tiangen) and the concentration of RNA was determined by NanoDrop 2000. Extracted RNA was reverse-transcribed into cDNA with FastQuant RT kit (Tiangen) and the cDNA were subjected to ABI 7900HT or ABI Q6 with SYBR Green (Tiangen) for qPCR. Serial minutes at room temperature, incubated with detergent solution for 5 minutes. Probe sets specific for viral (-) RNA were hybridized to the cells at 40 for 3 hours, pre-amplifier and amplifier DNA probes were sequentially inoculated with cells at 40 , each for 30 minutes. Cells were then incubated with fluorescently labeled probes, specific to the amplifier DNA probes at 40 for 30 12 of 22 minutes. DAPI dying was conducted at last and coverslips were mounted onto a glass slide with Fluoromount Aqueous mounting medium (Sigma). Images were captured under the Olympus FV-1200 laser-scanning confocal microscopy and filter sets are as follows: DAPI-408nm, HAV RNA-550nm, HCV RNA -650nm, actin RNA-488nm. Pearson's correlation coefficient was calculated with the software FV10-ASM. For 3D reconstruction, one cell was scanned with approximately 8 optical slices along the Z-axis (0.63μm/slice) using confocal microscope FV-1200, then stacks of slices were processed by 3D blind deconvolution using AutoQuant X3. Analysis and projection of 3D images were used by Imaris. All images were captured and processed using the same parameter in order to compare RNA spot numbers and intensity in different cells.
Immunoprecipitation for pulling down HCV particles
The cell culture medium was first condensed to 10% primitive volume by Amicon®100K
Centrifugal Filter (Millipore)，then were incubated with Flag-affinity gel (Sigma) at 4 overnight.
After washing the gel with 1×PBS 10 times, Flag-peptide(Sigma) equal to 5 × bed volumes of Flagaffinity gel was used for eluting HCV particles. TCID50 and RT-qPCR were applied to measure viral infectivity and RNA copy number in input and eluate. 
Cell viability and apoptosis detection assay
Statistical analysis
For the time course assay, significance value was calculated by multiple t-tests in Prism6. For image analysis, significance value was calculated by Mann Whitney test in Prism6. P values under 0.05 were considered statistically significant and the following denotations were used: ***, P<0.001; **, P<0.01; * P<0.05.
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